Abdelali Haoudi

Abdelali Haoudi is the Vice President for Research for Qatar Foundation. Dr. Haoudi has been a faculty at the Department of Microbiology and Molecular Cell Biology at Eastern Virginia Medical School, USA. Dr. Haoudi’s main research interests are centered around the molecular basis and the development of therapeutic approaches for cancer, viral oncology, and functional genomics (proteomics). He has held different positions as a Scientist, Visiting Scientist, or Visiting Professor in some of the leading biomedical research institutes worldwide, including Pasteur Institute, Paris, France, National Institutes of Health, USA, and Harvard Institute of Proteomics at Harvard Medical School, USA. In 2001, Dr. Haoudi founded the Journal of Biomedicine and Biotechnology. This journal is listed on many important literature databases, including PubMed, and in 2006 it has a respectable impact factor of approximately 2. This is impressive since impact factors are calculated on citations within the last two years, and the journal has only been in existence for a few years. In 2003, Dr. Haoudi has founded the International Council of Biomedicine and Biotechnology with a main mission of promoting and supporting Biomedical Research and Biotechnology in developing countries both in the academic and private sector with the support of world renowned experts including Nobel Laureates in medicine. In 2006, Dr. Haoudi has been elected as a member of the National Royal Academy of Sciences and Technology (Hassan II Academy for Science and Technology) of the Kingdom of Morocco, which is a prestigious institution whose membership is granted by His Majesty Mohamed VI, King of Morocco. In 2007, Dr. Haoudi has been recruited to join Qatar Foundation as the Vice President for Research.

Biography Updated on 4 September 2007

Articles in Scholarly Journals [Incomplete List]

  1. LINE-1 Retrotransposition: Impact on Genome Stability and Diversity and Human Disease
    Journal of Biomedicine and Biotechnology, vol. 2006, Article ID 37049, 2 pages, 2006
  2. Neurodegenerative Diseases: Mechanisms and Therapies
    Journal of Biomedicine and Biotechnology, vol. 2006, Article ID 47539, 2 pages, 2006
  3. RNA Interference
    Journal of Biomedicine and Biotechnology, vol. 2006, Article ID 89018, 2 pages, 2006
  4. PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo
    Blood, vol. 107, no. 5, pp. 1980–1988, 2006
  5. Cancer Cell International, vol. 6, no. 1, p. 13, 2006
  6. Bioinformatics and data mining in proteomics
    Expert Review of Proteomics, vol. 3, no. 3, pp. 333–343, 2006
  7. Data Mining in Genomics and Proteomics
    Journal of Biomedicine and Biotechnology, vol. 2005, no. 2, pp. 63–64, 2005
  8. Functional Clustering Algorithm for High-Dimensional Proteomics Data
    Journal of Biomedicine and Biotechnology, vol. 2005, no. 2, pp. 80–86, 2005
  9. A novel approach for clustering proteomics data using Bayesian fast Fourier transform
    Bioinformatics, vol. 21, no. 10, pp. 2210–2224, 2005
  10. Retrotransposition-Competent Human LINE-1 Induces Apoptosis in Cancer Cells With Intact p53
    Journal of Biomedicine and Biotechnology, vol. 2004, no. 4, pp. 185–194, 2004
  11. Human T-cell Leukemia Virus-I Tax Oncoprotein Functionally Targets a Subnuclear Complex Involved in Cellular DNA Damage-Response
    Journal of Biological Chemistry, vol. 278, no. 39, pp. 37736–37744, 2003
  12. The HTLV-1 Tax Oncoprotein Attenuates DNA Damage Induced G1 Arrest and Enhances Apoptosis in p53 Null Cells
    Virology, vol. 305, no. 2, pp. 229–239, 2003
  13. Postgenomics: Proteomics and Bioinformatics in Cancer Research
    Journal of Biomedicine and Biotechnology, vol. 2003, no. 4, pp. 217–230, 2003
  14. Vanadium and tellurium siloxane compounds as precursors of vanadium oxide and tellurium oxide silica materials
    International Journal of Inorganic Materials, vol. 3, no. 4-5, pp. 357–366, 2001
  15. Genetica, vol. 109, no. 1/2, pp. 61–70, 2000
  16. Reverse transcriptase can stabilize or destabilize the genome
    Genome, vol. 43, no. 6, pp. 949–956, 2000
  17. Developmental expression analysis of the 1731 retrotransposon reveals an enhancement of Gag–Pol frameshifting in males of Drosophila melanogaster
    Gene, vol. 196, no. 1-2, pp. 83–93, 1997
  18. The Gag polypeptides of the Drosophila 1731 retrotransposon are associated to virus-like particles and to nuclei
    FEBS Letters, vol. 377, no. 1, pp. 67–72, 1995